tóng-àn:Immune checkpoints of immunosuppressive actions associated with breast cancer.svg

頁面內容不支援其他語言。
Che sī chi̍t hūn tùi Wikimedia Commons ín--lâi ê tóng-àn
Wikipedia (chū-iû ê pek-kho-choân-su) beh kā lí kóng...

Choân kái-sek-tō͘(SVG ùng-giông, chék-cháung: 512 × 402 chuông-só, ùng-giông duâi-nâung:654 KB)

Khài-iàu

Soat-bêng
English: Immune checkpoints of inhibitory pathways are fundamental in the immune system to maintain self-tolerance and modulate immune responses. In breast cancer, some of these immune checkpoints and immunosuppressive factors have been associated with subtype specificity through their expressions on breast cancer cells. The different immune cells and their ligand-receptor interactions and secreted stimulatory growth factors, chemokines and cytokines are shown. The expression of these immune markers in the TME in breast cancer may or not be subtype-specific but are important in circumventing immune recognition or to immobilize effector T cells. Thus, the expression of these ligands and receptors may be associated with breast cancer stage and clinical outcome. (AKT. serine/threonine kinase or protein kinase B; ARG1. Arginase 1; Bcl-xL. B-cell lymphoma-xtra large; CAFs. Cancer-associated fibroblasts; CTLA4. cytotoxic T-lymphocyte-associated protein 4; ER− Estrogen Receptor Negative; GM-CSF. Granulocyte-Macrophage Colony-Stimulating Factor; HER2+. Human Epidermal Growth Factor Receptor 2; IDO. Indoleamine-2,3-dioxygenase; IFN-γ. interferon gamma; IFN-γR. interferon gamma receptor; IL. Interleukin; JAK. Janus kinase; iNOS. Inducible nitric oxide synthase; MDSC. Myeloid-derived suppressor cells; MHC. major histocompatibility complex; MMP. Matrix Metalloproteinases; mTOR. Mammalian target of rapamycin; MUC. Mucins; NK. natural killer; NF-κB. nuclear factor-κB; NLR. Neutrophil-lymphocyte ratio; NO. Nitric Oxide; PI3K. PI3K.phosphoinositide 3-kinase; PD-1. programmed death-1; PD-L1. Programmed death-ligand1; PGE2. Prostaglandin E2; PR−. Progesterone Receptor Negative; ROS. Reactive Oxygen Species; SHP. Src homology protein-tyrosine phosphatase; Siglec 9. Sialic acid-binding lectins 9; STAT. Signal transducer and activator of transcription; TAMs. Tumor-associated macrophages; TANs. Tumor-associated neutrophils; TGF-β. Transforming Growth Factor-beta; TIL. Tumor-Infiltrating Lymphocytes; TNBC. Triple Negative Breast Cancer; Treg. regulatory T cell; TCR. T cell receptor; VEGF. Vascular endothelial growth factor).[1]
Ji̍t-kî
Chhut-chhù https://doi.org/10.3390/cancers11081205
Chok-chiá Vanessa Barriga, Nyanbol Kuol, Kulmira Nurgali, and Vasso Apostolopoulos

Siū-khoân

w:zh:創用CC
標示名姓
此檔案採用創用CC 姓名標示 4.0 國際授權條款。
你會使自由:
  • 分享 – kho͘-pih, hoat-pò͘ kap thoân-pò͘ pún chok
  • 重新修改 – kái-pian pún chok-phín
Àn i-hā ê tiâu-kiāⁿ
  • 標示名姓 – 您必須指名出正確的製作者,和提供授權條款的連結,以及表示是否有對內容上做出變更。您可以用任何合理的方式來行動,但不得以任何方式表明授權條款是對您許可或是由您所使用。
  1. Template:CC-notice

說明

添加單行說明來描述出檔案所代表的內容
Immune checkpoints of immunosuppressive actions associated with breast cancer

在此檔案描寫的項目

描繪內容 繁體中文

著作權狀態 繁體中文

有著作權 繁體中文

授權條款 繁體中文

多媒體型式 繁體中文

image/svg+xml

Tóng-àn le̍k-sú

Chhi̍h ji̍t-kî/sî-kan, khoàⁿ hit sî-chūn--ê tóng-àn.

Ji̍t-kî/Sî-kan細張圖寸尺Iōng-chiáChù-kái
hiān-chāi2020-nî 4-goe̍h 8-ji̍t (pài-saⁿ) 20:202020-nî 4-goe̍h 8-ji̍t (pài-saⁿ) 20:20版本的細圖512 × 402(654 KB)Rob HurtUploaded a work by Vanessa Barriga, Nyanbol Kuol, Kulmira Nurgali, and Vasso Apostolopoulos from https://doi.org/10.3390/cancers11081205 Add to Library with UploadWizard

Í-hā ê ia̍h liân kàu chit ê iáⁿ-siōng:

tóng-àn hō͘ lâng sái--ê chōng-hóng

Ē-kha--ê kî-thaⁿ wiki ēng tio̍h chit--ê tóng-àn:

元資料